AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 295: E1076-E1083, 2008. First published September 9, 2008; doi:10.1152/ajpendo.90408.2008
0193-1849/08 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/5/E1076    most recent
90408.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sutherland, L. N.
Right arrow Articles by Wright, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sutherland, L. N.
Right arrow Articles by Wright, D. C.

Time course of high-fat diet-induced reductions in adipose tissue mitochondrial proteins: potential mechanisms and the relationship to glucose intolerance

Lindsey N. Sutherland, Lauren C. Capozzi, N. Joan Turchinsky, Rhonda C. Bell, and David C. Wright

Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada

Submitted 30 April 2008 ; accepted in final form 31 August 2008


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Increasing evidence suggests that reduced adipose tissue mitochondrial content is associated with the pathogenesis of type 2 diabetes. These investigations have utilized severely insulin-resistant rodent models. Thus, it is difficult to ascertain the potential mechanisms that initiate these changes and whether reductions in adipose mitochondria are an initiating event in the development of impaired glucose homeostasis. Thus, we sought to determine the time course of high-fat diet-induced reductions of mitochondrial content in epididymal adipose tissue in relation to changes in purported mediators of mitochondrial biogenesis and the development of impaired glucose homeostasis. Male Wistar rats were fed a high-fat diet (~59% of kcals from fat) for 2, 4, or 6 wk. Six weeks of high-fat feeding resulted in reductions in CORE I, COX IV, cytochrome c, HSP60, relative mtDNA copy number, and PGC-1{alpha} expression. These changes were not associated with decreases in eNOS and AMPK or increases in markers of oxidative stress. Interestingly, ex vivo treatment of adipose tissue cultures with palmitate led to decreases in PGC-1{alpha} expression and COX IV and CORE I protein content as observed in vivo. Thus, the high-fat diet-induced reductions in adipose tissue mitochondrial proteins may be mediated by increases in plasma fatty acids. Importantly, reductions in adipose tissue mitochondrial content occurred after the development of impaired glucose homeostasis. Thus, reductions in adipose tissue mitochondrial proteins are most likely not a causal event in the development of impaired glucose homeostasis.

peroxisome proliferator-activated receptor-{gamma} coactivator-1; insulin resistance; obesity; rat; type 2 diabetes

ADIPOSE TISSUE HAS CLASSICALLY BEEN VIEWED as an inert storage depot for excess calories. However, it is now widely recognized that adipose is an active endocrine organ and that derangements in adipose tissue function and morphology are closely associated with impaired glucose homeostasis (24). For example, mounting evidence has suggested that reductions in adipose tissue mitochondrial content are involved in the pathogenesis of type 2 diabetes. In support of this hypothesis it has been shown that the protein content of mitochondrial respiratory chain enzymes such as, ubiquinone:cytochrome c oxidoreductase core I subunit (CORE I), cytochrome c oxidase subunit IV (COX IV), and cytochrome c are reduced in epididymal adipose tissue and adipocytes of genetically modified, insulin-resistant rodents (4, 13, 29, 30). A similar pattern of reduced mitochondrial content has been reported in subcutaneous adipose tissue samples obtained from individuals with type 2 diabetes (1). Interestingly, the insulin sensitizing effects of thiazolendiones (TZDs) are closely matched by robust increases in adipose tissue mitochondrial biogenesis (1, 4, 30).

Reductions in adipose tissue mitochondrial content in insulin-resistant states could likely be the result of decreases in the expression of peroxisome proliferator-activated receptor-{gamma} (PPAR{gamma}) coactivator-1{alpha} (PGC-1{alpha}), a transcriptional coactivator that has been shown to control the expression of mitochondrial genes in white adipocytes (27). For instance, PGC-1{alpha} expression is reduced in abdominal adipose tissue from insulin-resistant rodents (29) and in subcutaneous adipose tissue samples from insulin-resistant subjects (12) and individuals with type 2 diabetes (1).

It seems likely that decreases in PGC-1{alpha} expression could be a result of reductions in signaling pathways that induce PGC-1{alpha} expression and reciprocal increases in the activation of processes that downregulate this transcriptional coactivator. For instance, endothelial nitric oxide synthase (eNOS) (18, 29) and 5'-AMP-activated protein kinase (AMPK) (20, 22) have been linked to the induction of PGC-1{alpha} expression in white adipose tissue and the content and/or activity of these proteins are decreased in adipose tissue from severely insulin-resistant rodents (21, 29). On the other hand, it has recently been argued that hyperglycemia, elevations in free fatty acids, and/or the induction of oxidative stress can all lead to decreases in the expression of PGC-1{alpha} and reductions in mitochondrial content (2, 7).

The majority of studies that have explored the regulation of adipose tissue mitochondrial content have utilized genetic rodent models of severe insulin resistance. Although these investigations are useful in establishing associations between physiological end points, they are limited by the severe and prolonged insulin resistance present in these animals. Consequently, these studies lend little insight into the cellular events that trigger reductions in adipose tissue mitochondrial content and the relationship of these changes to the development of systemic insulin resistance. Establishing the temporal relationships between these variables will not only allow us to more accurately define the potential regulators of adipose tissue mitochondrial biogenesis in a physiological setting, but more importantly will help to determine whether reductions in adipose tissue mitochondrial content are an early, and perhaps causal, event in the development of impaired glucose homeostasis. Within this context, the purpose of the present investigation was to determine the time course of high-fat diet-induced reductions in adipose tissue mitochondrial content in relation to changes in reputed mediators of mitochondrial biogenesis and the development of impaired glucose homeostasis. Given the close association between adipose tissue mitochondrial content and systemic insulin sensitivity, we hypothesized that reductions in adipose tissue mitochondria would occur prior to, or concurrent with, the onset of impaired glucose tolerance.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Materials. Reagents, molecular weight marker, and nitrocellulose membranes for SDS-PAGE were purchased from Bio-Rad (Mississauga, ON, Canada). ECL Plus was a product of Amersham Pharmacia Biotech (Arlington Heights, IL). Antibodies against COX IV and CORE I were purchased from Molecular Probes (Eugene, OR). Phosphospecific (Thr172) AMPK{alpha} antibodies were from Cell Signaling (Danvers, MA). An anti-eNOS antibody was purchased from BD Transduction Laboratories (Mississauga, ON, Canada). Antibodies against heat shock protein-60 (HSP60) and cytochrome c were from Stressgen (Victoria, BC, Canada) and Mitosciences (Eugene, OR), respectively. An antibody against β-actin was a product of Sigma (St. Louis, MO). Horseradish peroxidase-conjugated donkey anti-rabbit and goat anti-mouse IgG secondary antibodies were purchased from Jackson ImmunoResearch Laboratories (West Grove, PA). Glucose standards were obtained from NERL Diagnostics (East Providence, RI) and glucose reagents from Diagnostic Chemicals Limited (PEI, Canada). Rat insulin enzyme-linked immunosorbent assay (ELISA) kits and adiponectin ELISA kits were purchased from Linco (St. Charles, MO). A nonesterified fatty acid (NEFA) assay kit was a product of Wako Diagnostics (Richmond, VA). RNeasy and DNeasy extraction kits were purchased from Qiagen (Mississauga, ON, Canada). SuperScript II Reverse Transcriptase was a product of Invitrogen (Burlington, ON, Canada). Taqman Gene Expression Assays for β-actin, were from Applied Biosytems (Foster City, CA). Forward and reverse primers for PGC-1{alpha}, β-actin, and mitochondrial D-loop were from Integrated DNA Technologies(Coraville, IA), while probes for these genes were from Applied Biosystems. Assay kits for thiobarbituric acid reactive substance (TBARS) and protein carbonyls were purchased from Cayman Chemicals (Ann Arbor, MI). All other chemicals were purchased from Sigma.

Treatment of rats. All protocols followed Canadian Council on Animal Care guidelines and were approved by the Animal Use and Welfare Committee at the University of Alberta. Male Wistar rats (Charles River, Wilmington, MA) weighing ~200 g were housed two per cage with a 12:12-h light-dark cycle and were provided with water and standard rat chow ad libitum. Rats were acclimated to the animal housing facility for 1 wk prior to the start of the diet manipulation. Rats continued to receive either standard rat chow or were fed a high-fat diet ad libitum for 2, 4, or 6 wk. The standard chow diet contained 28.5% protein, 13.5% fat, and 58.0% carbohydrates, expressed as percentage of total energy. The high-fat diet contained 21% protein (casein), 59% fat (21.07% corn oil, 37.92% lard), and 20% carbohydrate, expressed as percentage of total energy. The diets were similarly enriched with protein, vitamins, fiber, and minerals.

Intraperitoneal glucose tolerance tests. After a 12-h overnight fast, animals received an intraperitoneal injection of glucose (2 g/kg body wt) between 8 AM and 10 AM. Blood was collected into heparinized tubes (Fisher Scientific, Edmonton, AB, Canada) from the tail veins at 0 min (prior to injection) and 15, 30, 45, 60, 90, and 120 min after injection. Whole blood was placed on ice and centrifuged for separation of plasma, and plasma was stored at –20°C until further analysis. Changes in glucose and insulin over time were plotted, and the area under the curve (AUC) was calculated for each. The product of the glucose and insulin AUCs was calculated, as this can be used as a marker of systemic insulin action (6, 26).

Determination of plasma glucose, insulin, leptin, adiponectin and NEFAs. Plasma glucose was analyzed using the glucose oxidase method. Samples were analyzed in triplicate on a microplate reader. The average coefficient of variation (CV) for this assay in our laboratory is <5%. Plasma insulin, leptin, and adiponectin were measured using ELISA assay kits specific for rat. Samples were run in triplicate, and the average CVs of these assays are <5%. NEFAs were measured in duplicate on a 96-well plate using a commercially available kit.

Adipose tissue collection. Animals were anesthesized with pentabaritol sodium (5m g/100 g body wt). Epididymal adipose tissue was dissected free of the testes and immediately weighed. A portion was kept for adipose tissue organ culture, and the remainder was clamp frozen in tongs cooled to the temperature of liquid nitrogen and then stored at –80°C until further analysis.

Adipose tissue organ culture. Adipose tissue organ culture is a well-characterized technique that has previously been used to study alterations in adipose tissue metabolism and gene expression (9, 10, 14, 28). Under sterile conditions, ~500 mg of epididymal fat from each animal was placed into culture dishes containing 15 ml of M-199 supplemented with 1% antibiotic-antimycotic, 50 µU/ml insulin, and 2.5 nm dexamethasone. The tissue was minced into 1- to 2-mg pieces and placed in an incubator maintained at 37°C with a gas phase of 5% CO2. After 24 h, palmitate complexed to 7.5% BSA, or an equivalent volume of vehicle, was added to a final concentration of 500 µM. To study the effects of prolonged hyperinsulinemia on PGC-1{alpha} expression, M-199 was supplemented with 2 mU/ml insulin or vehicle. After a 24-h incubation, the culture medium containing the adipose tissue minces was poured into ice-cold PBS and then filtered to remove the adipose tissue minces for storage at –80°C.

Western blotting. Clamp-frozen epididymal fat was homogenized in 2 volumes of ice-cold buffer containing cell lysis buffer (BioSource) supplemented with protease inhibitor cocktail (Sigma) and phenylmethylsulfonyl fluoride. Homogenized samples were sonicated for 5 s and centrifuged for 15 min at 2,500 g at 4°C. The fat cake was carefully removed, and the protein concentration of the supernatant was determined using the BCA method. The CV for this assay is <5% in our laboratory. The protein content of CORE 1, COX IV, HSP60, eNOS, p-AMPK, and cytochrome c were determined by Western blot analysis as described previously (31, 32). Briefly, equal amounts of protein were separated on either 10% (CORE 1, HSP60, eNOS, p-AMPK) or 15% (COX IV, cytochrome c) gels. Proteins were wet-transferred to nitrocellulose membranes for 90 min at 200 mA/tank. Membranes were blocked in tris-buffered saline-0.01% Tween 20 (TBST) supplemented with 5% nonfat dry milk for 1 h at room temperature with gentle agitation. Membranes were incubated in TBST-5% nonfat dry milk supplemented with appropriate primary antibodies overnight at 4°C with gentle agitation. The following morning, blots were briefly washed in TBST and then incubated in TBST-1% nonfat dry milk supplemented with horseradish peroxidase-conjugated secondary antibodies for 1 h at room temperature. Bands were visualized using ECL plus and captured using a Typhoon Imaging system (GE Health Care). Imagequant software was used to quantify relative band intensities. β-Actin was used as an internal control. In preliminary experiments we found that 6 wk of high-fat feeding had no effect on the protein content of β-actin in epididymal adipose tissue (3.21 ± 0.12 chow fed, 3.48 ± 0.23 high-fat fed, arbitrary densitometric units n = 6).

Real-time PCR. RNA was isolated from epididymal adipose tissue using an RNeasy kit according to the manufacturer's instructions. One microgram of RNA was used for the synthesis of complementary DNA (cDNA) using SuperScript II Reverse Transcriptase, oligo(dT), and dNTP. Real-time PCR was performed using a 7900HT Fast Real-Time PCR system (Applied Biosystems). A Taqman Gene Expression Assay was used to determine the expression of β-actin. Primers and probes for PGC-1{alpha} were designed using Primer Express 3.0 software (sequences are available upon request). Samples were run in duplicate in a 96-well plate format. For the determination of β-actin, each well (20 µl total volume) contained 1 µl of gene expression assay, 1 µl of cDNA template, 10 µl of Taqman Fast Universal PCR Master Mix, and 8 µl of RNAase-free water. For PGC-1{alpha}, each 20-µl reaction contained 10 µl of PCR Master mix, 0.225 µl each of forward and reverse primers, 0.05 µl of probe, and 5.55 µl of RNAase-free water. β-Actin was used as the reference gene, as we had found in preliminary experiments that β-actin expression did not change with high-fat feeding (P = 0.43). Relative differences in gene expression between chow- and high-fat-fed rats were determined using the 2Formula(cycle threshold) method (15). Standard curve assays were performed for beta actin and the genes of interest. The amplification efficiencies of the gene of interest and β-actin were equivalent as determined using the equation 10(–1/slope) – 1. Likewise, when plotting log cDNA dilution vs. {Delta}CT (CT gene of interest – CT β-actin), the slope of this relationship was <0.1, indicating that the genes of interest were amplified with equal efficiency.

Mitochondrial DNA copy number. Total DNA was isolated from epididymal adipose tissue by use of a DNeasy kit. Genomic DNA samples were treated with RNase to remove contaminating RNA. Relative mitochondrial DNA (mtDNA) copy number was measured by determining the ratio of a mtDNA target sequence (mitochondrial D-loop) to the expression of a nuclear target sequence (β-actin) by real-time PCR. These target genes have previously been used to determine relative amounts of mtDNA in rat tissue (3, 17). Primers and probes for β-actin and the mitochondrial D-loop were designed using Primer Express 1.5 software (sequences are available upon request). Samples were run in duplicate using a 96-well plate format using a 7900HT Fast Real-Time PCR system (Applied Biosystems). Each well contained 10 µl of master mix, 0.225 µl each of forward and reverse primers, 0.05 µl of probe, 1 µl of genomic DNA, and 8.5 µl of RNAse-free water. Relative differences in mtDNA copy number between chow- and high-fat-fed rats were determined using 2Formula, as described by Nicklas et al. (17). Briefly, the CT for β-actin was subtracted from the CT for the mitochondrial D-loop to generate {Delta}CT. Chow-fed rats acted as the control standard and {Delta}{Delta}CT was determined as {Delta}CT from high-fat fed – {Delta}CT from chow fed. Mitochondrial D-loop and β-actin were amplified with equal efficiency (slope of DNA dilution vs. {Delta}CT <0.1).

Determination of adipose tissue thiobarbituric acid-reactive substances and protein carbonyls. Epididymal adipose tissue samples (~500 mg) were homogenized in 2 volumes of cell extraction buffer followed by centrifugation for 10 min at 2,500 g at 4°C. The fat cake was carefully removed, and the protein concentration of the resulting supernatant was determined. Lipid peroxidation, a marker of oxidative damage to lipids, was determined by measuring the formation of malondialdehyde (MDA)-thiobarbituric acid (TBA) adducts using a commercially available kit (Cayman Chemicals, Ann Arbor, MI). Changes in thiobarbituric acid-reactive substance (TBAR) formation were determined colormetrically at 532 nm using a 96-well format. Similarly, oxidative damage to proteins was determined through measuring the formation of protein carbonyls with an assay kit from Cayman Chemicals. Protein carbonyl formation was detected using a microplate reader at a wavelength of 370 nm. The CV for these assays is <10% in our laboratory.

Statistical analysis. Data are presented as means ± SE. Comparisons between the means of chow and high-fat groups at the same time point were made using an unpaired Student's t-test. Statistical significance was set at P < 0.05.


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
Effect of high-fat feeding on body weight, fat pad mass, and blood measurements. Significant differences in body mass and epididymal fat pad mass between control and high-fat-fed rats were evident at all time points (table 1). Fasting glucose levels were slightly elevated following 6 wk of high-fat feeding. High-fat feeding lead to increases in fasting insulin and leptin levels at all time points examined while having no effect on plasma adiponectin concentrations. NEFA concentrations were elevated in high-fat-fed rats following 6 wk of feeding.


View this table:
[in this window]
[in a new window]

  		Table 1. Time course of high-fat diet-induced changes in body weight, epididymal fat pad mass, and plasma hormones and metabolites

 
High-fat diet-induced reductions in adipose tissue mitochondrial content. High-fat feeding for 6 wk led to ~30–50% reductions in the protein content of various markers of mitochondrial content, CORE I, COX IV, and cyochrome c in epididymal adipose tissue (Fig. 1). No changes were seen following either 2 or 4 wk of high-fat feeding. In addition to reductions in constituents of the respiratory chain, we saw decreases in the mitochondrial chaperone protein HSP60. Similarly 6 wk of high-fat feeding led to reductions in relative mtDNA copy number and the expression of PGC-1{alpha} (Fig. 2).


Figure 1
View larger version (29K):
[in this window]
[in a new window]

  		Fig. 1. High-fat feeding results in reductions in the protein content of mitochondrial marker proteins ubiquinone:cytochrome c oxidoreductase core I subunit (CORE I; A), cytochrome c oxidase subunit IV (COX IV; B), cytochrome c (C), and heat shock protein (HSP)60 (D) in epididymal adipose tissue. Data are presented as means + SE for 8–13 samples per group. High-fat-fed values are expressed relative to chow-fed control values at the same time point. Representative blots are shown for each protein of interest and for β-actin, which was used as an internal loading control. *P < 0.05 vs. corresponding chow-fed control value.

 

Figure 2
View larger version (9K):
[in this window]
[in a new window]

  		Fig. 2. Six weeks of high-fat feeding results in decreases in relative mitochondrial (mt) DNA copy number and PGC-1{alpha} mRNA expression. Data are presented as means + SE for 6–8 samples per group are expressed relative to chow-fed values at the same time point. *P < 0.05.

 
High-fat diet-induced changes in AMPK signaling, eNOS protein content, and oxidative stress. Having determined the earliest time point in which reductions in adipose tissue mitochondrial content with high-fat feeding occurs, we wanted to determine whether these changes were associated with parallel decreases in AMPK and eNOS, reputed mediators of mitochondrial biogenesis in white adipose tissue. Six weeks of high-fat feeding did not result in decreases in AMPK phosphorylation or total protein content. Likewise, eNOS protein in epididymal adipose tissue was not decreased. High-fat feeding for 6 wk did not lead to increases in protein carbonyl formation or MDA, markers of oxidative stress (Fig. 3).


Figure 3
View larger version (15K):
[in this window]
[in a new window]

  		Fig. 3. High-fat feeding does not result in decreases in AMPK phosphorylation (A), AMPK{alpha} protein content (B), endothelial NO synthase (eNOS) protein content (C), or increases in thiobarbituric acid-reactive substances (TBARS; D) and lipid peroxides (E) in rat epididymal adipose tissue. Data are presented as means + SE for 6–11 samples per group. For Western blot data, high-fat-fed values are expressed relative to chow fed-control values at the same time point. Representative blots are shown for each protein of interest and for β-actin, used as an internal loading control.

 
Palmitate decreases PGC-1{alpha} expression in adipose tissue. Epididymal adipose tissue minces were incubated in M-199 supplemented with or without 500 µM palmitate for 24 h. This treatment led to a ~50% reduction in PGC-1{alpha} expression. Hyperinsulinemia (24-h incubation with 2 mU/ml insulin) had no effect on PGC-1{alpha} expression (data not shown). The palmitate-induced reductions in PGC-1{alpha} expression was associated with decreases in COX IV and CORE I protein content (Fig. 4).


Figure 4
View larger version (11K):
[in this window]
[in a new window]

  		Fig. 4. Palmitate decreases the expression of PPAR{gamma} coactivator-1{alpha} (PGC-1{alpha}; A) and mitochondrial proteins (B) in epididymal adipose tissue ex vivo. Data are presented as means + SE for 4–6 samples per group. For Western blot data, representative blots are shown for each protein of interest and for β- actin, used as an internal loading control. *P < 0.05.

 
Time course of high-fat diet-induced alterations in glucose homeostasis. High-fat feeding led to impairments in glucose clearance and an exaggerated insulin response to an intraperitoneal glucose challenge in rats fed a high-fat diet for 4 and 6 wk (Fig. 5). The glucose-insulin AUC index (integrated AUC) can be used as a surrogate of whole body insulin action (6, 26) with increases in this value representing a worsening of systemic insulin action. As seen in Fig. 5C, high-fat feeding led to marked increases in the glucose-insulin AUC index.


Figure 5
View larger version (12K):
[in this window]
[in a new window]

  		Fig. 5. High-fat feeding causes impaired glucose tolerance and reductions in whole body insulin action. Area under the curve (AUC) calculations for the glucose and insulin responses to an intraperitoneal glucose tolerance test following 2, 4, or 6 wk of high-fat feeding are shown for 3–8 animals per group. The glucose-insulin AUC index was used as a marker of whole body insulin action and is the product of the glucose and insulin AUCs. *P < 0.05 vs. the corresponding chow-fed value at the same time point.

 

   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
Adipose tissue is increasingly being recognized as an important player in the regulation of whole body glucose metabolism. Of interest to the study of type 2 diabetes, a strong association between reductions in adipose tissue mitochondrial content and systemic insulin resistance has been reported. Data from these investigations have been generated primarily using adipose tissue or adipocytes from genetically modified rodents such as db/db mice and fa/fa rats (4, 13, 29, 30). Unfortunately, due to the marked insulin resistance and hyperglycemia present in these animals, it is difficult to identify the specific mechanisms that trigger reductions in adipose tissue mitochondrial content and whether decreases in adipose tissue mitochondria are a potential initiating event in the pathogenesis of systemic insulin resistance and glucose intolerance. With these points in mind, we sought to determine how quickly reductions in adipose tissue mitochondrial content occurs with high-fat feeding, a common approach used to cause abdominal obesity and insulin resistance in rodents.

Compared with chow-fed controls, 6 wk of high-fat feeding led to ~30–50% reductions in the content of mitochondrial respiratory-chain proteins CORE I, COX IV, and cytochrome c. Likewise, we found similar reductions in mtHSP60, a chaperone protein involved in mitochondrial protein folding that has been previously shown to be decreased in epididymal adipose tissue from ob/ob (30) and db/db mice (19). Confirming our Western blot data, we found reductions in relative mtDNA copy number, a marker of the number of mitochondria per cell. Importantly, our data demonstrate that 6 wk of high-fat feeding is the earliest time point in which reductions in adipose tissue mitochondrial protein content is evident. The magnitude of this reduction is similar to what has been reported in db/db mice and fa/fa rats (4, 13, 29, 30), yet develops in the absence of prolonged hyperglycemia and hyperinsulinemia.

PGC1-{alpha} is a transcriptional coactivator and master regulator of mitochondrial biogenesis (8). Reductions in PGC-1{alpha} expression have been reported in insulin-resistant rodents (23, 29) and in obese and type 2 diabetic subjects (1, 25). Likewise, the induction of mitochondrial biogenesis in adipose tissue by thiazolidienediones is accompanied by increases in PGC-1{alpha} expression (1, 30). In accord with these findings, we found decreases in PGC-1{alpha} expression concurrent with reductions in adipose tissue mitochondrial marker proteins. These results are temporally consistent with the notion that reductions in PGC-1{alpha} expression could be involved in mediating high-fat diet-induced decreases in adipose tissue mitochondrial proteins.

The regulation of PGC-1{alpha} expression and mitochondrial biogenesis in adipose tissue is a complex process involving multiple factors. In models of severe insulin resistance, positive effectors of mitochondrial biogenesis in adipose tissue such as AMPK (21) and eNOS (29) are reduced. On the other hand negative modulators of mitochondrial content (2), such as oxidative stress, are increased in adipose tissue from diabetic mice (11). In the current investigation, we assessed whether changes in these variables occurred concurrently with the initial reductions in markers of mitochondrial content caused by high-fat feeding. Following 6 wk of high-fat feeding, a time point in which markers of mitochondrial content were reduced, AMPK phosphorylation and eNOS content were unchanged. Consistent with a recent report in high-fat-fed mice (16), we did not find any differences in protein carbonyl or MDA content in adipose tissue from high-fat-fed rats. Collectively our results suggest that alterations in AMPK, eNOS, and oxidative stress are not initiating events in the process mediating decreases in adipose tissue mitochondrial protein content.

Given these results, we sought to identify potential mechanisms that could help explain high-fat diet-induced reductions in adipose tissue mitochondrial content. In our high-fat feeding model rats maintain normal glucose levels but are both hyperinsulinemic and hyperlipidemic. Given the fact that palmitate has previously been shown to reduce the expression of PGC-1{alpha} in skeletal muscle cells (5, 7), we wanted to determine if the ex vivo treatment of rat adipose tissue with palmitate could reproduce the effects of high-fat feeding on adipose tissue PGC-1{alpha} expression and markers of mitochondrial content. We found that palmitate, but not high insulin levels, led to reductions in PGC-1{alpha} expression and COX IV and CORE I protein content. These findings, in combination with the observed increases in NEFA levels following high-fat feeding, suggest a potential causal role for fatty acids in the downregulation of adipose tissue PGC-1{alpha} expression and mitochondrial content.

To determine the relevance of the observed reductions in adipose tissue mitochondrial proteins to the development of insulin resistance, we measured changes in glucose homeostasis following 2, 4, and 6 wk of high-fat feeding. Contrary to our hypothesis, yet consistent with what has been reported in skeletal muscle (2), we found that reductions in adipose tissue mitochondrial content occurred after the development of high-fat diet-induced insulin resistance. These findings are temporally inconsistent with the notion that reductions in adipose tissue mitochondrial content are a causal, initiating event in the development of impaired glucose homeostasis. Rather, the present findings argue that reductions in adipose tissue mitochondrial content develop as a consequence of high-fat diet-induced insulin resistance. It should be pointed out that we did not measure mitochondrial function in the present study. Thus, it still remains a possibility that reductions in adipose tissue mitochondrial function, independent of changes in mitochondrial content, could precede and be linked to the development of systemic insulin resistance. Furthermore, our results do not rule out the possibility that reductions in adipose tissue mitochondrial content may be associated with a further worsening of systemic insulin resistance.

This investigation is the first to characterize the temporal relationships between reductions in adipose tissue mitochondrial content, the potential mediators of this process, and changes in whole body glucose homeostasis in a model of diet-induced obesity. We found that reductions in adipose tissue mitochondrial content are associated with reductions in PGC-1{alpha} expression and that these effects can be reproduced ex vivo by treating adipose tissue organ cultures with palmitate. The most important finding of this study is that alterations in PGC-1{alpha} and mitochondrial markers occured after the onset of impaired glucose homeostasis. Although the present findings in rat epididymal fat pads cannot necessarily be extrapolated to visceral fat depots in humans, our results argue against reductions in adipose tissue mitochondrial content being an initiating event in the development of impaired glucose homeostasis.


   GRANTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
D. C. Wright is an Alberta Heritage Foundation for Medical Research Scholar, Canadian Institutes of Health Research (CIHR) New Investigator and Canadian Diabetes Association Scholar. This research was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada to R. C. Bell and an Operating Grant to D. C. Wright from CIHR.


   ACKNOWLEDGMENTS
 
We thank Donna Taylor and Abha Hoedel for outstanding technical assistance with the glucose tolerance tests.


   FOOTNOTES
 

Address for reprint requests and other correspondence: D. C. Wright, Alberta Diabetes Institute, 4126C HRIF East, Univ. of Alberta, Edmonton Alberta Canada T6G 2E1 (e-mail: dcw3{at}ualberta.ca)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Bogacka I, Xie H, Bray GA, Smith SR. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes 54: 1392–1399, 2005.[Abstract/Free Full Text]
  2. Bonnard C, Durand A, Peyrol S, Chanseaume E, Chauvin MA, Morio B, Vidal H, Rieusset J. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Invest 118: 789–800, 2008.[Web of Science][Medline]
  3. Branda RF, Brooks EM, Chen Z, Naud SJ, Mischler SA, Nicklas JA. Nucleic acid deletions and copy number in rats. Comp Med 52: 359–362, 2002.[Web of Science][Medline]
  4. Choo HJ, Kim JH, Kwon OB, Lee CS, Mun JY, Han SS, Yoon YS, Yoon G, Choi KM, Ko YG. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia 49: 784–791, 2006.[CrossRef][Web of Science][Medline]
  5. Coll T, Jove M, Rodriguez-Calvo R, Eyre E, Palomer X, Sanchez RM, Merlos M, Laguna JC, Vazquez-Carrera M. Palmitate-mediated downregulation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha in skeletal muscle cells involves MEK1/2 and nuclear factor-kappaB activation. Diabetes 55: 2779–2787, 2006.[Abstract/Free Full Text]
  6. Cortez MY, Torgan CE, Brozinick JT Jr, Ivy JL. Insulin resistance of obese Zucker rats exercise trained at two different intensities. Am J Physiol Endocrinol Metab 261: E613–E619, 1991.[Abstract/Free Full Text]
  7. Crunkhorn S, Dearie F, Mantzoros C, Gami H, da Silva WS, Espinoza D, Faucette R, Barry K, Bianco AC, Patti ME. Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation. J Biol Chem 282: 15439–15450, 2007.[Abstract/Free Full Text]
  8. Finck BN, Kelly DP. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 116: 615–622, 2006.[CrossRef][Web of Science][Medline]
  9. Fried SK, Moustaid-Moussa N. Culture of adipose tissue and isolated adipocytes. Methods Mol Biol 155: 197–212, 2001.[Medline]
  10. Fried SK, Russell CD, Grauso NL, Brolin RE. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest 92: 2191–2198, 1993.[Web of Science][Medline]
  11. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114: 1752–1761, 2004.[CrossRef][Web of Science][Medline]
  12. Hammarstedt A, Jansson PA, Wesslau C, Yang X, Smith U. Reduced expression of PGC-1 and insulin-signaling molecules in adipose tissue is associated with insulin resistance. Biochem Biophys Res Commun 301: 578–582, 2003.[CrossRef][Web of Science][Medline]
  13. Koh EH, Park JY, Park HS, Jeon MJ, Ryu JW, Kim M, Kim SY, Kim MS, Kim SW, Park IS, Youn JH, Lee KU. Essential role of mitochondrial function in adiponectin synthesis in adipocytes. Diabetes 56: 2973–2981, 2007.[Abstract/Free Full Text]
  14. Lee MJ, Wang Y, Ricci MR, Sullivan S, Russell CD, Fried SK. Acute and chronic regulation of leptin synthesis, storage, and secretion by insulin and dexamethasone in human adipose tissue. Am J Physiol Endocrinol Metab 292: E858–E864, 2007.[Abstract/Free Full Text]
  15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(–Delta Delta CT) Method. Methods 25: 402–408, 2001.[CrossRef][Web of Science][Medline]
  16. Matsuzawa-Nagata N, Takamura T, Ando H, Nakamura S, Kurita S, Misu H, Ota T, Yokoyama M, Honda M, Miyamoto KI, Kaneko S. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism 57: 1071–1077, 2008.[CrossRef][Web of Science][Medline]
  17. Nicklas JA, Brooks EM, Hunter TC, Single R, Branda RF. Development of a quantitative PCR (TaqMan) assay for relative mitochondrial DNA copy number and the common mitochondrial DNA deletion in the rat. Environ Mol Mutagen 44: 313–320, 2004.[CrossRef][Web of Science][Medline]
  18. Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, Sciorati C, Bracale R, Valerio A, Francolini M, Moncada S, Carruba MO. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 299: 896–899, 2003.[Abstract/Free Full Text]
  19. Okamoto Y, Higashiyama H, Rong JX, McVey MJ, Kinoshita M, Asano S, Hansen MK. Comparison of mitochondrial and macrophage content between subcutaneous and visceral fat in db/db mice. Exp Mol Pathol 83: 73–83, 2007.[CrossRef][Web of Science][Medline]
  20. Orci L, Cook WS, Ravazzola M, Wang MY, Park BH, Montesano R, Unger RH. Rapid transformation of white adipocytes into fat-oxidizing machines. Proc Natl Acad Sci USA 101: 2058–2063, 2004.[Abstract/Free Full Text]
  21. Pang J, Choi Y, Park T. Ilex paraguariensis extract ameliorates obesity induced by high-fat diet: Potential role of AMPK in the visceral adipose tissue. Arch Biochem Biophys 476: 178–185, 2008.[CrossRef][Web of Science]
  22. Pirinen E, Kuulasmaa T, Pietila M, Heikkinen S, Tusa M, Itkonen P, Boman S, Skommer J, Virkamaki A, Hohtola E, Kettunen M, Fatrai S, Kansanen E, Koota S, Niiranen K, Parkkinen J, Levonen AL, Yla-Herttuala S, Hiltunen JK, Alhonen L, Smith U, Janne J, Laakso M. Enhanced polyamine catabolism alters homeostatic control of white adipose tissue mass, energy expenditure, and glucose metabolism. Mol Cell Biol 27: 4953–4967, 2007.[Abstract/Free Full Text]
  23. Prpic V, Watson PM, Frampton IC, Sabol MA, Jezek GE, Gettys TW. Adaptive changes in adipocyte gene expression differ in AKR/J and SWR/J mice during diet-induced obesity. J Nutr 132: 3325–3332, 2002.[Abstract/Free Full Text]
  24. Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444: 847–853, 2006.[CrossRef][Web of Science][Medline]
  25. Semple RK, Crowley VC, Sewter CP, Laudes M, Christodoulides C, Considine RV, Vidal-Puig A, O'Rahilly S. Expression of the thermogenic nuclear hormone receptor coactivator PGC-1alpha is reduced in the adipose tissue of morbidly obese subjects. Int J Obes Relat Metab Disord 28: 176–179, 2004.[CrossRef][Web of Science][Medline]
  26. Steen MS, Foianini KR, Youngblood EB, Kinnick TR, Jacob S, Henriksen EJ. Interactions of exercise training and ACE inhibition on insulin action in obese Zucker rats. J Appl Physiol 86: 2044–2051, 1999.[Abstract/Free Full Text]
  27. Tiraby C, Tavernier G, Lefort C, Larrouy D, Bouillaud F, Ricquier D, Langin D. Acquirement of brown fat cell features by human white adipocytes. J Biol Chem 278: 33370–33376, 2003.[Abstract/Free Full Text]
  28. Trujillo ME, Lee MJ, Sullivan S, Feng J, Schneider SH, Greenberg AS, Fried SK. Tumor necrosis factor alpha and glucocorticoid synergistically increase leptin production in human adipose tissue: role for p38 mitogen-activated protein kinase. J Clin Endocrinol Metab 91: 1484–1490, 2006.[Abstract/Free Full Text]
  29. Valerio A, Cardile A, Cozzi V, Bracale R, Tedesco L, Pisconti A, Palomba L, Cantoni O, Clementi E, Moncada S, Carruba MO, Nisoli E. TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J Clin Invest 116: 2791–2798, 2006.[CrossRef][Web of Science][Medline]
  30. Wilson-Fritch L, Nicoloro S, Chouinard M, Lazar MA, Chui PC, Leszyk J, Straubhaar J, Czech MP, Corvera S. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest 114: 1281–1289, 2004.[CrossRef][Web of Science][Medline]
  31. Wright DC, Geiger PC, Han DH, Jones TE, Holloszy JO. Calcium induces increases in peroxisome proliferator-activated receptor gamma coactivator-1alpha and mitochondrial biogenesis by a pathway leading to p38 mitogen-activated protein kinase activation. J Biol Chem 282: 18793–18799, 2007.[Abstract/Free Full Text]
  32. Wright DC, Han DH, Garcia-Roves PM, Geiger PC, Jones TE, Holloszy JO. Exercise-induced mitochondrial biogenesis begins before the increase in muscle PGC-1alpha expression. J Biol Chem 282: 194–199, 2007.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 J. Physiol.Home page
V. J. Vieira and R. J. Valentine
Mitochondrial biogenesis in adipose tissue: can exercise make fat cells \#8216;fit'?
J. Physiol., July 15, 2009; 587(14): 3427 - 3428.
[Full Text] [PDF]

Home page
 J. Physiol.Home page
M. J. Laye, R. S. Rector, S. O. Warner, S. P. Naples, A. L. Perretta, G. M. Uptergrove, M. H. Laughlin, J. P. Thyfault, F. W. Booth, and J. A. Ibdah
Changes in visceral adipose tissue mitochondrial content with type 2 diabetes and daily voluntary wheel running in OLETF rats
J. Physiol., July 15, 2009; 587(14): 3729 - 3739.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
D. B. Williams, L. N. Sutherland, M. R. Bomhof, S. A. U. Basaraba, A. B. Thrush, D. J. Dyck, C. J. Field, and D. C. Wright
Muscle-specific differences in the response of mitochondrial proteins to {beta}-GPA feeding: an evaluation of potential mechanisms
Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1400 - E1408.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
L. N. Sutherland, M. R. Bomhof, L. C. Capozzi, S. A.U. Basaraba, and D. C. Wright
Exercise and adrenaline increase PGC-1{alpha} mRNA expression in rat adipose tissue
J. Physiol., April 1, 2009; 587(7): 1607 - 1617.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/5/E1076    most recent
90408.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sutherland, L. N.
Right arrow Articles by Wright, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sutherland, L. N.
Right arrow Articles by Wright, D. C.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.